Panacea Life Sciences Holdings, Inc.
PLSH
$0.0539
$0.005912.29%
| Weiss Ratings | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Very Weak | |||
| Risk Grade | E+ | |||
| Reward Grade | E | |||
| Rating Factors | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Very Weak | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 3.29 | |||
| Price History | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 8.89% | |||
| 30-Day Total Return | -1.82% | |||
| 60-Day Total Return | -11.78% | |||
| 90-Day Total Return | -40.11% | |||
| Year to Date Total Return | 115.60% | |||
| 1-Year Total Return | -69.20% | |||
| 2-Year Total Return | -71.56% | |||
| 3-Year Total Return | -92.30% | |||
| 5-Year Total Return | -- | |||
| 52-Week High % Change | -86.29% | |||
| 52-Week Low % Change | 92.00% | |||
| Price | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.35 | |||
| 52-Week Low Price | $0.03 | |||
| 52-Week Low Price (Date) | Dec 31, 2024 | |||
| 52-Week High Price (Date) | Apr 08, 2024 | |||
| Valuation | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 996.45K | |||
| Enterprise Value | 22.74M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.46 | |||
| Earnings Per Share Growth | -16.72% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.29 | |||
| Price/Book (Q) | -0.09 | |||
| Enterprise Value/Revenue (TTM) | 8.23 | |||
| Price | $0.05 | |||
| Enterprise Value/EBITDA (TTM) | -6.25 | |||
| Enterprise Value/EBIT | -4.28 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 16.49M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 800-985-0515 | |||
| Address | 5910 South University Boulevard Greenwood Village, CO 80121 | |||
| Website | www.panacealife.com | |||
| Country | United States | |||
| Year Founded | 2008 | |||
| Profitability | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -192.24% | |||
| Profit Margin | -277.51% | |||
| Management Effectiveness | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -18.47% | |||
| Return on Equity | -- | |||
| Income Statement | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 2.76M | |||
| Total Revenue (TTM) | 2.76M | |||
| Revenue Per Share | $0.17 | |||
| Gross Profit (TTM) | -3.86M | |||
| EBITDA (TTM) | -3.64M | |||
| EBIT (TTM) | -5.31M | |||
| Net Income (TTM) | -7.67M | |||
| Net Income Avl. to Common (TTM) | -7.67M | |||
| Total Revenue Growth (Q YOY) | 55.93% | |||
| Earnings Growth (Q YOY) | 19.27% | |||
| EPS Diluted (TTM) | -0.46 | |||
| EPS Diluted Growth (Q YOY) | 26.73% | |||
| Balance Sheet | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 117.10K | |||
| Cash Per Share (Q) | $0.01 | |||
| Total Current Assets (Q) | 4.64M | |||
| Total Preferred Equity (Q) | 0.00 | |||
| Total Equity (Q) | -9.62M | |||
| Current Ratio (Q) | 0.228 | |||
| Book Value Per Share (Q) | -$0.53 | |||
| Total Assets (Q) | 17.41M | |||
| Total Current Liabilities (Q) | 20.39M | |||
| Total Debt (Q) | 21.86M | |||
| Total Liabilities (Q) | 27.04M | |||
| Total Common Equity (Q) | -9.62M | |||
| Cash Flow | PLSH - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -55.10K | |||
| Cash from Financing (TTM) | 1.66M | |||
| Net Change in Cash (TTM) | 34.40K | |||
| Levered Free Cash Flow (TTM) | -170.90K | |||
| Cash from Operations (TTM) | -1.57M | |||
